Morningstar

PharmaJet®, a World Leader in Needle-Free Injection Systems, is Initiating the Development of Needle-Free Self-Injection Pens for Home Use

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...
Yahoo Finance

PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis ® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...
Business Wire

WHO Launching Polio Eradication Campaign in Pakistan Using PharmaJet Precision Delivery System

5 million Needle-free PharmaJet Tropis ® ID syringes are being provided for polio immunization campaigns. Published results show that the Tropis System is a preferred and effective solution to help ...
Business Wire

PharmaJet Partner Zydus Cadila Announces Emergency Use Authorization Approval for World’s First Plasmid DNA COVID-19 Vaccine

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila, has received the Emergency Use Authorization ...
Business Insider

GeoVax and PharmaJet to Collaborate On Development of Needle-Free Vaccine for Zika Virus

GeoVax Zika Virus Vaccine Provided 100% Protection in Animal Challenge Model ATLANTA, GA, Aug. 21, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human ...
MarketWatch

Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans

HONG KONG, June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration ...
MarketWatch

PharmaJet's Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data

The MarketWatch News Department was not involved in the creation of this content. -- PharmaJet's intramuscular (IM) Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ ...